Compounds > spirogermanium
Page last updated: 2024-08-23

spirogermanium and Carcinoma, Non-Small Cell Lung

spirogermanium has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blum, R; Chang, AY; Donehower, RC; Ettinger, DS; Finkelstein, DM; Green, M; Hahn, RG; Ruckdeschel, JC1
Blough, RR; Cobleigh, MA; Evrard, M; Hange, P; Johnson, CM; Lad, TE; Shevrin, DP1

Trials

1 trial(s) available for spirogermanium and Carcinoma, Non-Small Cell Lung

ArticleYear
Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): an Eastern Cooperative Oncology Group study.
    Medical and pediatric oncology, 1989, Volume: 17, Issue:3

    Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Formamides; Germanium; Humans; Idarubicin; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Prognosis; Random Allocation; Remission Induction; Spiro Compounds

1989

Other Studies

1 other study(ies) available for spirogermanium and Carcinoma, Non-Small Cell Lung

ArticleYear
Phase II trial of spirogermanium in advanced non-small cell lung cancer. An Illinois Cancer Council Study.
    Investigational new drugs, 1989, Volume: 7, Issue:2-3

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Spiro Compounds

1989